Articles by author: Sandi Colner
Artificial intelligence (AI) is often associated with consumer-facing and mainstream industries such as gaming, securities and retail, but it plays just as crucial of a role in the biopharma industry. Sandi Colner, head of lab and life sciences vertical for Intel, and Stephanie Davies, head of science for cell therapy at ValitaCell, joined Host […]
Latest
Verizon Leaders: Unlocking Connectivity with the Verizon Partner Network
For a special episode of The Verizon Partner Network the focus was on the considerable role of partnerships in the Verizon Partner Program and the leaders shared their perspectives on the initiative. Their conversation brought about a lot of thought-providing context on the evolving telecommunications landscape. In today’s era, collaboration and integration are key to […]
Mark Tina Envisions Differences to the Verizon Partner Network in 2024
In the dynamic telecommunications landscape, Verizon’s Partner Network continues to evolve, adapting to new trends and opportunities. For another segment featuring Mark Tina, VP of Indirect Channel Distribution and Channel Chief at Verizon Business Group, he explores exactly what types of significant changes and advancements the Verizon Partner Network will see in 2024. In this […]
Mark Tina Explores the Importance of Partners in Verizon Business Group Success
A special episode of The Verizon Partner Network focuses on an examination of an industry marked by fierce competition and rapid innovation. But most importantly, how the role of partnerships in a company’s success is increasingly vital. Mark Tina, the VP of Indirect Channel Distribution and Channel Chief at Verizon, details why partners are essential […]
AI and Cell Therapy Intersect to Revolutionize the Biopharma Industry
Artificial intelligence (AI) is often associated with consumer-facing and mainstream industries such as gaming, securities and retail, but it plays just as crucial of a role in the biopharma industry. Sandi Colner, head of lab and life sciences vertical for Intel, and Stephanie Davies, head of science for cell therapy at ValitaCell, joined Host […]